{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:02:01Z","timestamp":1788307321327,"version":"build-2803163510"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018367","name":"Swedish Foundation for MS Research","doi-asserted-by":"publisher","award":["None"],"award-info":[{"award-number":["None"]}],"id":[{"id":"10.13039\/100018367","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Poor adherence to secondary preventive medication after myocardial infarction (MI) negatively affects long-term prognosis, but knowledge is lacking regarding the impact of poor adherence on prognosis for patients with myocardial infarction with non-obstructive coronary arteries (MINOCA). We therefore investigated the effect of persistence to secondary preventive medication on prognosis in patients with MINOCA compared with patients with myocardial infarction with obstructive coronary arteries (MI-CAD).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>In this nationwide observational study of 116,143 patients with MI recorded in the SWEDEHEART registry between 2006\u25002017, MINOCA were identified in 9,124 patients and MI-CAD in 107,019 patients. Persistence to treatment with aspirin, statins, beta blockers and angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin-receptor blockers (ARBs) was investigated for 5 years post discharge and patients were followed for a composite endpoint of major adverse cardiovascular events (MACE), including all-cause death, MI, ischemic stroke and heart failure.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Persistent use of secondary preventive medications was associated with a decrease in the risk of MACE during follow-up in both MINOCA and MI-CAD patients; aspirin HR 0.70 (CI 0.60\u20130.82) vs. HR 0.60 (CI 0.57\u20130.64), statins HR 0.80 (CI 0.68\u20130.95) vs. HR 0.66 (CI 0.63\u20130.69), beta blockers HR 0.77 (CI 0.65\u20130.92) vs. HR 0.76 (CI 0.73\u20130.80) and ACEIs\/ARBs HR 0.62 (CI 0.50\u20130.77) vs. 0.67 (CI 0.63\u20130.71).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Persistence to secondary preventive medications after MI is associated with a reduction in the risk for MACE in both patients with MINOCA and MI-CAD. Continuous efforts to improve adherence to evidence-based medications in general to all patients with MI should be a priority.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0324533","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T17:22:48Z","timestamp":1748539368000},"page":"e0324533","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of persistence to secondary preventive medication on prognosis for patients with myocardial infarction with and without obstructive coronary arteries"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6531-1024","authenticated-orcid":true,"given":"Anna M.","family":"Nordenskj\u00f6ld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Lindhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0531-2516","authenticated-orcid":true,"given":"Bj\u00f6rn","family":"Wettermark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertil","family":"Lindahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"issue":"25","key":"pone.0324533.ref001","first-page":"2982","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study","volume":"76","author":"GA Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"pone.0324533.ref002","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1161\/CIR.0000000000000133","article-title":"2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"130","author":"EA Amsterdam","year":"2014","journal-title":"Circulation"},{"issue":"38","key":"pone.0324533.ref003","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC guidelines for the management of acute coronary syndromes","volume":"44","author":"RA Byrne","year":"2023","journal-title":"Eur Heart J"},{"issue":"38","key":"pone.0324533.ref004","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1093\/eurheartj\/eht295","article-title":"Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences","volume":"34","author":"R Chowdhury","year":"2013","journal-title":"Eur Heart J"},{"key":"pone.0324533.ref005","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.amjcard.2021.04.031","article-title":"Drug adherence and long-term outcomes in non-revascularized patients following acute myocardial infarction","volume":"152","author":"R Khan","year":"2021","journal-title":"Am J Cardiol"},{"issue":"6","key":"pone.0324533.ref006","article-title":"Medication non-adherence patterns and profiles for patients with incident myocardial infarction: observations from a large multi-morbid US population","volume":"53","author":"GYH Lip","year":"2023","journal-title":"Eur J Clin Invest"},{"issue":"9","key":"pone.0324533.ref007","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.amjmed.2011.12.013","article-title":"Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients","volume":"125","author":"SH Naderi","year":"2012","journal-title":"Am J Med"},{"issue":"8","key":"pone.0324533.ref008","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jacc.2016.06.005","article-title":"Assessing the impact of medication adherence on long-term cardiovascular outcomes","volume":"68","author":"S Bansilal","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"pone.0324533.ref009","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.114.011201","article-title":"Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries","volume":"131","author":"S Pasupathy","year":"2015","journal-title":"Circulation"},{"issue":"11","key":"pone.0324533.ref010","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.121.007880","article-title":"Survival in patients with suspected myocardial infarction with nonobstructive coronary arteries: a comprehensive systematic review and meta-analysis from the MINOCA global collaboration","volume":"14","author":"S Pasupathy","year":"2021","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"14","key":"pone.0324533.ref011","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","article-title":"2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"42","author":"J-P Collet","year":"2021","journal-title":"Eur Heart J"},{"issue":"18","key":"pone.0324533.ref012","article-title":"Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific Statement From the American Heart Association","volume":"139","author":"JE Tamis-Holland","year":"2019","journal-title":"Circulation"},{"key":"pone.0324533.ref013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2022.08.034","article-title":"Impact of secondary prevention medical therapies on outcomes of patients suffering from Myocardial Infarction with NonObstructive Coronary Artery disease (MINOCA): a meta-analysis","volume":"368","author":"O De Filippo","year":"2022","journal-title":"Int J Cardiol"},{"issue":"5","key":"pone.0324533.ref014","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2017.12.008","article-title":"Myocardial infarction with nonobstructive coronary arteries: the importance of achieving secondary prevention targets","volume":"131","author":"KM Eggers","year":"2018","journal-title":"Am J Med"},{"issue":"16","key":"pone.0324533.ref015","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1161\/CIRCULATIONAHA.116.026336","article-title":"Medical therapy for secondary prevention and long-term outcome in patients with myocardial infarction with nonobstructive coronary artery disease","volume":"135","author":"B Lindahl","year":"2017","journal-title":"Circulation"},{"key":"pone.0324533.ref016","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.3389\/fphar.2019.01606","article-title":"Secondary prevention medical therapy and outcomes in patients with myocardial infarction with non-obstructive coronary artery disease","volume":"10","author":"P Paolisso","year":"2020","journal-title":"Front Pharmacol"},{"issue":"20","key":"pone.0324533.ref017","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1136\/hrt.2010.198804","article-title":"The Swedish Web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies (SWEDEHEART)","volume":"96","author":"T Jernberg","year":"2010","journal-title":"Heart"},{"issue":"7","key":"pone.0324533.ref018","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/pds.1294","article-title":"The new Swedish Prescribed Drug Register--opportunities for pharmacoepidemiological research and experience from the first six months","volume":"16","author":"B Wettermark","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"pone.0324533.ref019","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish national inpatient register","volume":"11","author":"JF Ludvigsson","year":"2011","journal-title":"BMC Public Health"},{"issue":"11","key":"pone.0324533.ref020","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s10654-009-9350-y","article-title":"The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research","volume":"24","author":"JF Ludvigsson","year":"2009","journal-title":"Eur J Epidemiol"},{"key":"pone.0324533.ref021","article-title":"Adherence to secondary preventive treatment following myocardial infarction with and without obstructive coronary artery disease","author":"AM Nordenskjold","journal-title":"PLOS ONE"},{"issue":"4","key":"pone.0324533.ref022","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/sim.4067","article-title":"Multiple imputation using chained equations: Issues and guidance for practice","volume":"30","author":"IR White","year":"2011","journal-title":"Stat Med"},{"issue":"4","key":"pone.0324533.ref023","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jval.2010.10.033","article-title":"The association between statin use and outcomes potentially attributable to an unhealthy lifestyle in older adults","volume":"14","author":"AR Patrick","year":"2011","journal-title":"Value Health"},{"issue":"22","key":"pone.0324533.ref024","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1136\/hrt.2011.223289","article-title":"Overestimation of the effects of adherence on outcomes: a case study in healthy user bias and hypertension","volume":"97","author":"J LaFleur","year":"2011","journal-title":"Heart"},{"issue":"1","key":"pone.0324533.ref025","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12955-018-0921-z","article-title":"Relationships among medication adherence, lifestyle modification, and health-related quality of life in patients with acute myocardial infarction: a cross-sectional study","volume":"16","author":"Y-M Lee","year":"2018","journal-title":"Health Qual Life Outcomes"},{"issue":"5","key":"pone.0324533.ref026","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s11606-010-1609-1","article-title":"Healthy user and related biases in observational studies of preventive interventions: a primer for physicians","volume":"26","author":"WH Shrank","year":"2011","journal-title":"J Gen Intern Med"},{"issue":"9","key":"pone.0324533.ref027","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.clinthera.2006.09.021","article-title":"Toward a standard definition and measurement of persistence with drug therapy: examples from research on statin and antihypertensive utilization","volume":"28","author":"PA Caetano","year":"2006","journal-title":"Clin Ther"},{"issue":"5","key":"pone.0324533.ref028","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2125.2012.04167.x","article-title":"A new taxonomy for describing and defining adherence to medications","volume":"73","author":"B Vrijens","year":"2012","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"pone.0324533.ref029","first-page":"143","article-title":"ESC working group position paper on myocardial infarction with non-obstructive coronary arteries","volume":"38","author":"S Agewall","year":"2017","journal-title":"Eur Heart J"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0324533","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T17:22:55Z","timestamp":1748539375000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0324533"}},"subtitle":[],"editor":[{"given":"Shukri","family":"AlSaif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":29,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0324533","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,29]]}}}